Abstract
Diseases of the circulatory system are the leading cause of sudden death in most European populations, and the main mechanisms of sudden cardiac death among all cardiovascular diseases are determined by disturbances in heart rhythm and conduction. In this regard, the problem of diagnosis and treatment of arrhythmias remains relevant. The Department of Surgical Treatment of Tachyarrhythmias has all the necessary resources to solve it, from the use of modern automatic devices that monitor the heart rhythm, to combined open-heart surgeries in patients with cardiac pathology and arrhythmias. Purpose of the publication: to present the results of the medical and scientific work of the Department for 2020. In 2020, the Department treated 1290 patients, of which 752 patients were operated with a total mortality rate of 0.13%. Another 117 operations were performed in patients undergoing treatment in other departments, which is 20% higher than in the previous year, mainly due to an increase in the number of catheter ablation procedures by 41%. Taking into account other departments, a total of 870 operations were performed (832 – closed and endovascular operations, 38 operations with artificial circulation), which is 2.8% less than last year. In 2020, a 5-fold increase in the number of implantations of cardioverter-defibrillators with an increase in the number of implantations of pacemakers by 5.3% should be noted. A new technology introduced this year is the implantation of a cardioverter-defibrillator with a fully subcutaneous electrode system. The main topics of scientific works are related to the issues of noninvasive topical and invasive electrophysiological diagnostics of various forms of arrhythmias, including genetically determined ones, the development of minimally invasive technologies, pacing and its complications. During the reporting year, 9 articles, 11 abstracts were published, 9 reports were delivered, lectures were held and test materials were developed for additional professional education courses in cardiac electrophysiology, standards of medical care for adults with atrial fibrillation were prepared.
References
- Cronin E.M., Bogun F.M., Maury P., Peichl P., Chen M., Namboodiri N. et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020; 17 (1): e2–e154. DOI: 10.1016/j.hrthm.2019.03.002
- Peretto G., Sala S., Rizzo S., Palmisano A., Esposito A., De Cobelli F. et al. Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. J. Am. Coll. Cardiol. 2020; 75 (9): 1046–57. DOI: 10.1016/j.jacc.2020.01.036
- Бокерия Л.А. (ред.) Здоровье России: Атлас. 15-е изд. М.; 2019. Bockeria L.A. (Ed.) Health of Russia: Atlas. 15-e izd. Moscow; 2019 (in Russ).
- Knecht S., Sohal M., Deisenhofer I., Albenque J.P., Arentz T., Neumann T. et al. Multicentre evaluation of non-invasive biatrial mapping for persistent atrial fibrillation ablation: the AFACART study. Europace. 2017; 19 (8): 1302–9. DOI: 10.1093/europace/euw168
- König S., Ueberham L., Müller-Röthing R., Wiedemann M., Ulbrich M., Sause A. et al. Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the German-wide helios hospital network of 5052 cases. Europace. 2020; 22 (1): 100–8. DOI: 10.1093/europace/euz260
- Hsia H.H., Xiong N. Mapping and ablation of ventricular arrhythmias in cardiomyopathies. Card. Electrophysiol. Clin. 2019; 11 (4): 635–55. DOI: 10.1016/j.ccep.2019.08.005
- Bockeria L.A., Pronicheva I.V., Serguladze S.Yu., Kvasha B.I., Kotanova E.S. Brugada syndrome and cross syndromes of cardiac sodium canalopathy: different masks of SCN5A gene mutations. Annals of Arrhythmology. 2018; 15 (1): 40–54 (in Russ). DOI: 10.15275/annaritmol.2018.1.5
- Pronicheva I.V., Serguladze S.Yu. The role of programmed ventricular stimulation in Brugada syndrome: whether an accurate assessment of risk of arrhythmic events is possible? Annals of Arrhythmology. 2019; 16 (3): 166–78 (in Russ). DOI: 10.15275/annaritmol.2019.3.7
- Serguladze S.Yu., Pronicheva I.V. Risk stratification and diagnostisis for Brugada syndrome: current status and developing ideas. Annals of Arrhythmology. 2020; 17 (1): 46–59 (in Russ). DOI: 10.15275/annaritmol.2020.1.6
- Friedman D.J., Parzynski C.S., Varosy P.D., Prutkin J.M., Patton K.K., Mithani A. et al. Trends and inhospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016; 1 (8): 900–11. DOI: 10.1001/jamacardio.2016.2782
- Boersma L., Barr C., Knops R., Theuns D., Eckardt L., Neuzil P. et al; EFFORTLESS Investigator Group. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: The EFFORTLESS Study. J. Am. Coll. Cardiol. 2017; 70 (7): 830–41. DOI: 10.1016/j.jacc.2017.06.040
- Quast A.B.E., Brouwer T.F., Tjong F.V.Y., Wilde A.A.M., Knops R.E. Clinical parameters to optimize patient 7-9 selection for subcutaneous and transvenous implantable defibrillator therapy. Pacing Clin. Electrophysiol. 2018; 41 (8): 990–5. DOI: 10.1111/pace.13411
- Probst V., Boveda S., Sadoul N., Marquié C., Chauvin M., Mondoly P. et al. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper. Arch. Cardiovasc. Dis. 2020; 113 (5): 359–66. DOI: 10.1016/j.acvd.2020.03.011
- Novikov A.V., Serguladze S.Yu. Infectious complications and tricuspid insufficiency after implantation of permanent pacing devices. Annals of Arrhythmology. 2019; 16 (4): 226–34 (in Russ). DOI: 10.15275/annaritmol. 2019.4.5
- Novikov A.V., Popov D.A., Serguladze S.Yu. A clinical case of reimplantation of a system for continuous pacing with simultaneous prosthetics of the tricuspid valve under conditions of active infection. Annals of Arrhythmology. 2019; 16 (4): 235–9 (in Russ.). DOI: 10.15275/annaritmol.2019.4.6
- Serguladze S.Yu., Lyubkina E.V., Kotanova E.S., Pronicheva I.V., Stepanova N.M. Topical diagnosis and results of recurrent ventricular arrhythmia ablation in a patient with non-ischemic cardiomyopathy. Annals of Arrhythmology. 2020; 17 (4): 265–72 (in Russ.). DOI: 10.15275/annaritmol.2020.4.6
- January C.T., Wann L.S., Calkins H., Chen L.Y., Cigarroa J.E., Cleveland J.C. Jr, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2019; 74 (1): 104–32. DOI: 10.1016/j.jacc.2019.01.011
- Hindricks G., Potpara T., Dagres N., Arbelo E., Bax J.J., Blomström-Lundqvist C. et al; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of CardioThoracic Surgery (EACTS). Eur. Heart J. 2020: ehaa612. DOI: 10.1093/eurheartj/ehaa612
- Kirchhof P., Benussi S., Kotecha D., Ahlsson A., Atar D., Casadei B. et al; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016; 37 (38): 2893–962. DOI: 10.1093/eurheartj/ehw210
- Van Laar C., Kelder J., van Putte B.P. The totally thoracoscopic maze procedure for the treatment of atrial fibrillation. Interact. Cardiovasc. Thorac. Surg. 2017; 24 (1): 102–11. DOI: 10.1093/icvts/ivw311
- Machino T., Tada H., Sekiguchi Y., Tanaka Y., Naito S., Yamasaki H. et al. Hybrid therapy of radiofrequency catheter ablation and percutaneous transvenous mitral commissurotomy in patients with atrial fibrillation and mitral stenosis. J. Cardiovasc. Electrophysiol. 2010; 21 (3): 284–9. DOI: 10.1111/j.1540-8167.2009.01625.x
- Zhou G.B., Hu J.Q., Guo X.G., Liu X., Yang J.D., Sun Q. et al. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. Int. J. Cardiol. 2016; 205: 72–80. DOI: 10.1016/j.ijcard.2015.12.004
- Kvasha B.I., Serguladze S.Yu., Pronicheva I.V., Lyubkina E.V., Sopov O.V., Matsonashvili G.R., Mustapaeva Z.V. Possibilities of surface electrocardiographic mapping in catheter ablation of atrial arrhythmias after surgical treatment of mitral heart disease. Annals of Arrhythmology. 2020; 17 (2): 97–110 (in Russ). DOI: 10.15275/annaritmol.2020.2.3
- Suladze V.G., Serguladze S.Yu., Matsonashvili G.R., Pronicheva I.V., Matsonashvili T.R., Kvasha B.I. Radiofrequency ablation of atrial tachyarrhythmia substrate by access from the non-coronary sinus of Valsalva. Annals of Arrhythmology. 2020; 17 (3): 152–61 (in Russ.). DOI: 10.15275/annaritmol.2020.3.1
- Serguladze S.Yu., Pronicheva I.V., Dishekov M.R., Lyubkina E.V., Kuznetsova E.V. Electrophysiological features and possibilities of ablation of ectopic atrial tachycardia from the area of non-coronary aortic valve leaflet. Annals of Arrhythmology. 2019; 16 (4): 204–16 (in Russ). DOI: 10.15275/annaritmol.2019.4.3
- Platonov P.G., McNitt S., Polonsky B., Rosero S.Z., Kutyifa V., Huang A. et al. Risk stratification of type 2 long-QT syndrome mutation carriers with normal QTc interval: the value of sex, T-wave morphology, and mutation type. Circ. Arrhythm. Electrophysiol. 2018; 11 (7): e005918. DOI: 10.1161/CIRCEP.117.005918
- Shima Y., Horigome H., Nozaki Y., Lin L., Ishiodori T., Yano Y. et al. Successful trans-maternal nadolol pharmacotherapy in a fetus presenting with long QT syndrome type 2 complicated by torsade de pointes. J. Cardiol. Cases. 2020; 22 (6): 265–8. DOI: 10.1016/j.jccase.2020.07.006
- Shimizu W., Makimoto H., Yamagata K., Kamakura T., Wada M., Miyamoto K. et al. Association of genetic and clinical aspects of congenital long QT syndrome with life-threatening arrhythmias in Japanese patients. JAMA Cardiol. 2019; 4 (3): 246–54. DOI: 10.1001/jamacardio. 2018.4925
- Mazzanti A., Maragna R., Vacanti G., Monteforte N., Bloise R., Marino M. et al. Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome. J. Am. Coll. Cardiol. 2018; 71 (15): 1663–71. DOI: 10.1016/j.jacc.2018.01.078
- König S., Ueberham L., Müller-Röthing R., Wiedemann M., Ulbrich M., Sause A. et al. Catheter ablation of ventricular arrhythmias and in-hospital mortality: insights from the german-wide helios hospital network of 5052 cases. Europace. 2020; 22 (1): 100–8. DOI: 10.1093/europace/euz260
- Hsia H.H., Xiong N. Mapping and ablation of ventricular arrhythmias in cardiomyopathies. Card. Electrophysiol. Clin. 2019; 11 (4): 635–55. DOI: 10.1016/j.ccep.2019.08.005. PMID: 31706471
- Jaïs P., Maury P., Khairy P., Sacher F., Nault I., Komatsu Y. et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012; 125 (18): 2184–96. DOI: 10.1161/CIRCULATIONAHA.111.043216
- Desjardins B., Crawford T., Good E., Oral H., Chugh A., Pelosi F. et al. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009; 6 (5): 644–51. DOI: 10.1016/j.hrthm.2009.02.018
- Chopra N., Tokuda M., Ng J., Reichlin T., Nof E., John R.M. et al. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy. J. Cardiovasc. Electrophysiol. 2014; 25 (6): 602–8. DOI: 10.1111/jce.12393
- Yalin K., Golcuk E., Bilge A.K., Aksu T., Buyukbayrak H., Tiryakioglu S.K. et al. Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation. Europace. 2015; 17 (10): 1580–6. DOI: 10.1093/europace/euv013
About the authors
- Sergey Yu. Serguladze, Dr. Med. Sci., Professor, Head of Department, Cardiac Surgeon; ORCID
- Irina V. Pronicheva, Cand. Med. Sci., Senior Researcher, Cardiologist; ORCID
